Biote (BTMD) Asset Writedowns and Impairment (2021 - 2026)

Biote's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at -$433000.0 for Q1 2026.

• In Q1 2026, Asset Writedowns and Impairment fell 156.02% year-over-year to -$433000.0; the TTM figure through Mar 2026 stood at $515000.0 (down 53.81% YoY), while the FY2025 annual figure was $1.7 million, up 242.15% from the prior year.
• Asset Writedowns and Impairment was -$433000.0 for Q1 2026 at Biote, down from $135000.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $773000.0 in Q1 2025 to a low of -$433000.0 in Q1 2026.
• Historically, Asset Writedowns and Impairment has averaged $143687.5 across 5 years, with a median of $91500.0 in 2022.
• The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment plunged 176.8% in 2022, then jumped 515.0% in 2023.
• A 5-year view of Asset Writedowns and Impairment shows it stood at -$235000.0 in 2022, then soared by 395.74% to $695000.0 in 2023, then plunged by 125.9% to -$180000.0 in 2024, then jumped by 175.0% to $135000.0 in 2025, then sank by 420.74% to -$433000.0 in 2026.
• The last three Asset Writedowns and Impairment figures came in at -$433000.0 (Q1 2026), $135000.0 (Q4 2025), and $486000.0 (Q3 2025), per Business Quant data.